Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 7, 2013, Pages 873-878

  Guan, Xiaoxiang ^a,b   Wang, Li E ^b   Liu, Zhensheng ^b   Sturgis, Erich M ^b   Wei, Qingyi ^b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Biomarker; Genetic susceptibility; Genotype; Polymorphism

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P53; TP53 PROTEIN, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETICS; GENOTYPE; HEAD AND NECK TUMOR; HOMOZYGOTE; HUMAN; LUNG TUMOR; MALE; MELANOMA; MIDDLE AGED; POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; VERY ELDERLY; YOUNG ADULT;

BIOMARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEAD AND NECK NEOPLASMS; HOMOZYGOTE; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84880837723     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12076     Document Type: Article

References (15)

1. Gorlov IP, Gorlova OY, Frazier ML, et al. Evolutionary evidence of the effect of rare variants on disease etiology. Clin Genet. 2011; 79: 199-206.
2. Lefevre JH, Bonilla C, Colas C, et al. Role of rare variants in undetermined multiple adenomatous polyposis and early-onset colorectal cancer. J Hum Genet. 2012; 57: 709-16.
3. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet. 2008; 40: 695-701.
4. Gorlov IP, Gorlova OY, Sunyaev SR, et al. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet. 2008; 82: 100-12.
5. Egan KM, Nabors LB, Olson JJ, et al. Rare TP53 genetic variant associated with glioma risk and outcome. J Med Genet. 2012; 49: 420-1.
6. Stacey SN, Sulem P, Jonasdottir A, et al. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet. 2011; 43: 1098-103.
7. Zhou L, Yuan Q, Yang M. A functional germline variant in the P53 polyadenylation signal and risk of esophageal squamous cell carcinoma. Gene. 2012; 506: 295-7.
8. Wei S, Wang LE, McHugh MK, et al. Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility. Carcinogenesis. 2012; 33: 1531-7.
9. Liu Z, Ma H, Wei S, et al. Telomere length and TERT functional polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2011; 20: 2642-5.
10. Wang LE, Huang YJ, Yin M, et al. Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma. Eur J Cancer. 2011; 47: 107-15.
11. Yu H, Huang YJ, Liu Z, et al. Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck. Mol Carcinog. 2011; 50: 697-706.
12. Ma H, Zhou Z, Wei S, et al. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS ONE. 2011; 6: e20466.
13. Reinhardt HC, Schumacher B. The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends Genet. 2012; 28: 128-36.
14. Sullivan KD, Gallant-Behm CL, Henry RE, et al. The p53 circuit board. Biochim Biophys Acta. 2012; 1825: 229-44.
15. Soussi T. TP53 mutations in human cancer: database reassessment and prospects for the next decade. Adv Cancer Res. 2011; 110: 107-39.